Genetics of diabetes mellitus and diabetes complications (Q94600785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

review article

1 reference

title

Genetics of diabetes mellitus and diabetes complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

complications of diabetes mellitus

17 May 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

author name string

Jose C Florez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

publication date

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

17 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

17 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Economic Costs of Diabetes in the U.S. in 2017

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Worldwide access to treatment for end-stage kidney disease: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Concordance for islet autoimmunity among monozygotic twins

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

MODY: history, genetics, pathophysiology, and clinical decision making

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Type 2 Diabetes: Multiple Genes, Multiple Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Type 1 diabetes genome-wide association analysis with imputation identifies five new risk regions

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of type 2 diabetes-pitfalls and possibilities

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study of type 2 diabetes in Africa.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of Type 2 Diabetes in U.S. Hispanic/Latino Individuals: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of Type 2 Diabetes: the Power of Isolated Populations

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genomic insights into the causes of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Searching for missing heritability: designing rare variant association studies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Epidemiology of diabetes and diabetes-related complications.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Diabetic kidney disease: a report from an ADA Consensus Conference.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Is diabetic nephropathy an inherited complication?

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The Genetic Landscape of Renal Complications in Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic associations in diabetic nephropathy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

New susceptibility loci associated with kidney disease in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic basis of diabetic kidney disease and other diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The genetics of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Multiple loci associated with indices of renal function and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

New loci associated with kidney function and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

CUBN is a gene locus for albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association and functional follow-up reveals new loci for kidney function

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study of kidney function decline in individuals of European descent

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A catalog of genetic loci associated with kidney function from analyses of a million individuals

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Global prevalence and major risk factors of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Causes of blind certifications in England and Wales: April 1999–March 2000

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Visual impairment in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Diabetic retinopathy in identical twins

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Heritability of the severity of diabetic retinopathy: the FIND-Eye study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Heritability of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetics of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Exome-based case-control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Evaluation of patients with symptoms suggestive of chronic polyneuropathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Diabetic Neuropathy: A Position Statement by the American Diabetes Association.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Preventing foot ulcers in patients with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The epidemiology of lower extremity amputations in diabetic individuals

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Vascular risk factors and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Recent advances in exploring the genetic susceptibility to diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Identifying Common Genetic Risk Factors of Diabetic Neuropathies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Rare Nav1.7 variants associated with painful diabetic peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Heritability of carotid artery intima-medial thickness in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic risk score associations with cardiovascular disease and mortality in the Diabetes Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Interaction of type 2 diabetes mellitus with chromosome 9p21 rs10757274 polymorphism on the risk of myocardial infarction: a case-control study in Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Basal insulin and cardiovascular and other outcomes in dysglycemia

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12).

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Relationship between retinal and glomerular lesions in IDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Is diabetic retinopathy an independent risk factor for ischemic stroke?

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

A reference panel of 64,976 haplotypes for genotype imputation

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria

1 reference

https://api.crossref.org/works/10.1038%2FS41581-020-0278-5

7 January 2021

10.1038/S41581-020-0278-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32398868%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

1 reference